SARCODE BIOSCIENCE
SARcode Corporation is a private San Francisco based biopharmaceutical company engaged in the development of a novel class of small molecule lymphocyte function-associated antigen-1 (LFA-1; CD11a/CD18; ĂÂąLĂ²2) antagonists as a topical agent for the treatment of significant unmet medical needs in ophthalmology, dermatology and other inflammatory diseases.
SARCODE BIOSCIENCE
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2006-01-01
Address:
Brisbane, California, United States
Country:
United States
Website Url:
http://www.sarcode.com
Total Employee:
1+
Status:
Active
Contact:
650-416-7560
Email Addresses:
[email protected]
Total Funding:
98 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS AWS Global Accelerator Proofpoint Salesforce SPF NetNames DNS
Current Advisors List
Current Employees Featured
Investors List
Rho Capital Partners
Rho Capital Partners investment in Series B - SARcode Bioscience
Sofinnova Investments
Sofinnova Investments investment in Series B - SARcode Bioscience
Alta Partners
Alta Partners investment in Series B - SARcode Bioscience
Clarus Ventures
Clarus Ventures investment in Series B - SARcode Bioscience
Clarus Ventures
Clarus Ventures investment in Series A - SARcode Bioscience
Alta Partners
Alta Partners investment in Series A - SARcode Bioscience
Clarus Ventures
Clarus Ventures investment in Venture Round - SARcode Bioscience
Alta Partners
Alta Partners investment in Venture Round - SARcode Bioscience
